The new dispute resolution process is designed to use government officials to oversee disagreements, however, lobby group ...

The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva ...

The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection ...

An attorney for plaintiff Angela Valadez argued for a direct link between her cancer diagnosis and Zantac, which she took for ...

Magrish dismissed pharmaceutical industry arguments that pharmacy benefit managers, drug supply middlemen companies, have an ...

A proposed patent office depository for sealed settlements could expose pharmaceutical giants to antitrust scrutiny if ...

The North Carolina state treasurer is taking on drugmakers Novo Nordisk and Eli Lilly in an attempt to lower drug costs for ...

Rep. Cindy O'Laughlin, R-Shelbina, the Senate Floor Leader, said Big Pharma is trying to confuse legislators with unrelated ...

Under the deal, Walgreens will find candidates who are overweight or have obesity or diabetes and connect them with a Phase III clinical trial for Boehringer’s GLP-1 drug survodutide.

The warning letters don't specify how the drugmakers are flouting patent regulations, or what criteria the FTC uses to make that determination. The Federal Trade Commission on Tuesday challenged the ...

Veterinary drug producers in Vietnam are awaiting simplified procedures for drug conformity to get the go ahead, in order to ...

The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for ...